DB13045InvestigationalProtein Based Therapies
Racotumomab has been used in trials studying the treatment of Glioma, Wilm's Tumor, Neuroblastoma, Retinoblastoma, and Ewing's Sarcoma.
Resolves to
Compound
What you can answer from here — as of February 21, 2021
Which companies are running trials of Racotumomab, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account